Source:http://linkedlifedata.com/resource/pubmed/id/14993413
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2004-3-2
|
| pubmed:abstractText |
Despite important inroads into the molecular pathology of Alzheimer disease, effective long-term treatment for the condition remains elusive. Among the many gene products that are recognized as factors in the disease is apolipoprotein ( (apoE). The risk that specific isoforms of apoE pose with regard to Alzheimer Disease clearly varies, and so the roles that apoE plays in the brain will be crucial to a full understanding of the disease and to efforts to develop effective therapies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1534-0384
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
2
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
363-75, 339
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:14993413-Alzheimer Disease,
pubmed-meshheading:14993413-Amyloid,
pubmed-meshheading:14993413-Amyloid beta-Peptides,
pubmed-meshheading:14993413-Animals,
pubmed-meshheading:14993413-Apolipoproteins E,
pubmed-meshheading:14993413-Central Nervous System,
pubmed-meshheading:14993413-Genetic Predisposition to Disease,
pubmed-meshheading:14993413-Humans,
pubmed-meshheading:14993413-Mice
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Apolipoprotein E, amyloid, and Alzheimer disease.
|
| pubmed:affiliation |
Neuroscience Discovery Research, Lilly Research Laboratories Indianapolis, IN 46285, USA.
|
| pubmed:publicationType |
Journal Article,
Review
|